Medical director at Bridgeville suboxone clinic sentenced for unlawful dispensing of controlled substances


Date: December 9, 2021


Pittsburgh, PA — A resident of Wexford, Pennsylvania, has been sentenced in federal court to two years of probation and 100 hours of community service on his conviction of unlawfully distributing controlled substances, United States Attorney Cindy K. Chung announced today.

Senior United States District Judge Nora Barry Fischer imposed the sentence on Mark R. Foster.

According to information presented to the court, co-defendant Terry Brown owned and operated Cherry Way, a Suboxone clinic, located in Bridgeville PA, and Foster was a medical director at Cherry Way. Brown and Foster conspired together to create and submit unlawful prescriptions for Suboxone, Adderall and Percocet, and then unlawfully dispensed those controlled substances to Brown and to other persons not specifically named in the Indictment..

Assistant United States Attorney Robert R. Cessar prosecuted this case on behalf of the government.

The investigation leading to the filing of charges in this case was conducted by the Western Pennsylvania Opioid Fraud and Abuse Detection Unit (OFADU). The Western Pennsylvania OFADU, led by federal prosecutors in the U.S. Attorney's Office, combines the expertise and resources of federal and state law enforcement to address the role played by unethical medical professionals in the opioid epidemic.

The agencies which comprise the Western Pennsylvania OFADU include: Internal Revenue Service-Criminal Investigations, Federal Bureau of Investigation, U.S. Health and Human Services – Office of Inspector General, Drug Enforcement Administration, Pennsylvania Office of Attorney General - Medicaid Fraud Control Unit, Pennsylvania Office of Attorney General – Bureau of Narcotic Investigations, United States Postal Inspection Service, U.S. Attorney's Office – Criminal Division, Civil Division and Asset Forfeiture Unit, Department of Veterans Affairs-Office of Inspector General, Food and Drug Administration-Office of Criminal Investigations, U.S. Office of Personnel Management – Office of Inspector General and the Pennsylvania Bureau of Licensing.